Pain, nausea, and vomiting were the most frequently documented symptoms preceding unplanned acute care visits in patients with cancer, new research showed. Women, individuals from racial minority ...

A study conducted at the State University of Campinas (UNICAMP) in Brazil investigated the process of muscle pain chronification—that is, when it goes from acute to chronic—and identified one ...

The novel oral small molecule nonopioid suzetrigine was effective and well tolerated among patients with moderate to severe acute surgical and nonsurgical pain. Treatment of moderate to severe ...

There are many different medications to help with pain. Drugs in the non-opioid group are non-habit-forming and can address pain in various areas of the body. Non-opioid pain medications provide ...

Acute pain is sharp, sudden, and short-lived discomfort. It typically lasts only a brief time. Though it may not be serious, it could point to an underlying problem in some cases. Acute pain comes ...

Neuroscientists have shown that experiencing nature can alleviate acute physical pain. Surprisingly, simply watching nature videos was enough to relieve pain. Using functional magnetic resonance ...

LTG-001 demonstrated rapid absorption with a Tmax of approximately 1.5 hours. The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain.

Non-opioid and opioid medicines can be used to help manage different types of pain. Non-opioid medicines can also include prescription and over-the-counter medicines. Acute pain is a type of pain ...

The new drug is intended for treatment of moderate to severe acute pain in adults. Patients with acute pain after surgery or due to a broken bone or an injury are often prescribed opioid ...

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, the acting director of the FDA's Center for Drug Evaluation and ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with acute pain. The FDA has approved the non-opioid, highly selective ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid painkiller that could change the way doctors treat acute pain.